BioArctic AB (publ) (STO:BIOA.B)
Sweden · Delayed Price · Currency is SEK 322.60
+6.80 (2.15%)
Jul 28, 2026, 5:29 PM CET
BioArctic AB Income Statement
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 1,172 | 2,015 | 261.09 | 620.08 | 228.63 | 26.69 | |
Revenue Growth | -22.88% | 671.88% | -57.89% | 171.22% | 756.66% | - |
Cost of Revenue | 67.32 | 59.22 | 26.98 | 14.99 | - | - |
Gross Profit | 1,105 | 1,956 | 234.11 | 605.09 | 228.63 | 26.69 |
Selling, General & Admin | 201.23 | 194.83 | 148.84 | 172.18 | 148.67 | 97.35 |
Depreciation & Amortization Expenses | - | - | - | - | 14.63 | 13.11 |
Research & Development | 443.55 | 376.92 | 311.15 | 172.14 | 74.33 | 55.07 |
Other Operating Expenses | 65.81 | 125.54 | 2.64 | 8.13 | 8.34 | 0.89 |
Total Operating Expenses | 710.6 | 697.29 | 462.62 | 352.45 | 245.96 | 166.41 |
Operating Income | 394.35 | 1,259 | -228.52 | 252.64 | -17.34 | -139.72 |
Interest Income | 43.58 | 34.68 | 40.85 | 34.23 | 8.29 | 0.19 |
Interest Expense | -24.2 | -37.9 | -1.85 | -10.38 | -2.12 | -0.98 |
Other Non-Operating Income (Expense) | 19.38 | - | - | - | - | - |
Total Non-Operating Income (Expense) | 38.76 | -3.22 | 39 | 23.85 | 6.17 | -0.79 |
Pretax Income | 413.73 | 1,256 | -189.52 | 276.49 | -11.17 | -140.51 |
Provision for Income Taxes | 200.49 | 233.26 | -12.44 | 47.24 | 0.01 | -20.72 |
Net Income | 213.24 | 1,022 | -177.08 | 229.25 | -11.18 | -119.79 |
Net Income to Common | 213.24 | 1,022 | -177.08 | 229.25 | -11.18 | -119.79 |
Net Income Growth | -76.36% | - | - | - | - | - |
Shares Outstanding (Basic) | 89 | 89 | 88 | 88 | 88 | 88 |
Shares Outstanding (Diluted) | 89 | 89 | 89 | 88 | 89 | 89 |
Shares Change | 0.25% | 0.23% | 0.04% | -0.22% | 0.12% | - |
EPS (Basic) | 2.41 | 11.55 | -2.00 | 2.60 | -0.13 | -1.36 |
EPS (Diluted) | 2.40 | 11.52 | -2.00 | 2.59 | -0.13 | -1.36 |
EPS Growth | -76.42% | - | - | - | - | - |
Free Cash Flow | 1,253 | 1,421 | -342.97 | 302.25 | -44.38 | -144.84 |
Free Cash Flow Growth | - | - | - | - | - | - |
Free Cash Flow Per Share | 14.15 | 16.01 | -3.87 | 3.42 | -0.50 | -1.64 |
Dividends Per Share | 2.000 | 2.000 | - | - | - | - |
Dividend Growth | - | - | - | - | - | - |
Gross Margin | 94.26% | 97.06% | 89.66% | 97.58% | 100.00% | 100.00% |
Operating Margin | 33.64% | 62.46% | -87.52% | 40.74% | -7.58% | -523.54% |
Profit Margin | 18.19% | 50.73% | -67.82% | 36.97% | -4.89% | -448.85% |
FCF Margin | 106.91% | 70.50% | -131.36% | 48.74% | -19.41% | -542.73% |
EBITDA | 394.35 | 1,272 | -217.8 | 260.08 | -3.15 | -126.68 |
EBITDA Margin | 33.64% | 63.10% | -83.42% | 41.94% | -1.38% | -474.66% |
EBIT | 394.35 | 1,259 | -228.52 | 252.64 | -17.34 | -139.72 |
EBIT Margin | 33.64% | 62.46% | -87.52% | 40.74% | -7.58% | -523.54% |
Effective Tax Rate | 48.46% | 18.58% | 6.56% | 17.08% | -0.10% | 14.75% |